Provider licensing and credentials: Every provider who evaluates and prescribes GLP-1 medication should be a licensed, board-certified physician (MD or DO) or an advanced practice provider (NP or PA) with prescriptive authority
While uncomfortable, increased cold sensitivity is generally a physiological adaptation to weight loss rather than a concerning adverse reaction
Risks associated with mass-produced compounded GLP-1s Although the FDA has declared that the supply shortage is resolved, some companies continue to mass produce compounded versions of GLP-1s, claiming that the drugs are personalized for patient needs by altering the method of delivery (e.g., gummy, injection, spray) or adding unnecessary and unproven ingredients like B12 and glycine
But that situation can change at any time, and the same regulatory trajectory that closed off semaglutide and tirzepatide compounding applies here
Hcre Metab
Understanding which GLP-1 formulations cause less nausea, and employing practical strategies to manage symptoms, can significantly improve treatment adherence and patient outcomes